Murphy & Mullick Capital Management Corp Moderna, Inc. Transaction History
Murphy & Mullick Capital Management Corp
- $109 Billion
- Q4 2024
A detailed history of Murphy & Mullick Capital Management Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 578 shares of MRNA stock, worth $17,877. This represents 0.02% of its overall portfolio holdings.
Number of Shares
578Holding current value
$17,877% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
904Shares Held
235MCall Options Held
10.4MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.25 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.2 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$791 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$521 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA7.24MShares$224 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...